Rigaku XtaLAB Synergy-Custom X-ray diffraction system
THE WOODLANDS, Texas (PRWEB) January 29, 2018
The latest edition of Crystallography Times from Rigaku Corporation has been published and is available to view on the company’s global website.
A monthly electronic newsletter published by Rigaku Oxford Diffraction(ROD), Crystallography Times concentrates on single crystal X-ray diffraction, and serves the X-ray analysis community by presenting the latest news and crystallographic papers.
“Crystallography in the News” brings together the latest worldwide news and developments in small molecule and protein X-ray diffraction and showcases the newest research findings and advancements. Featured news stories include reports about the discovery by a team of Yale University researchers of an anti-aging protein which could play an important role in the treatment of multiple diseases ranging from diabetes to cancers. The findings indicated that the three-dimensional X-ray crystal structure of one of the proteins plays a large role in the regulation of longevity and metabolism.
Another news item reports that international team of scientists captured the crystal structure of the kappa opioid receptor — critical for providing pain relief — on the surface of human brain cells. They also made the discovery of a new opioid-based compound that, unlike current opioids, activates only the kappa opioid receptor, raising hopes that a painkiller that has no risk of addiction can be developed.
The Product Spotlight in the current issue features the Rigaku XtaLAB Synergy Custom single crystal X-ray diffraction system, a fully flexible Hybrid Photon Counting (HPC)-based system for laboratories requiring tailored solutions for their unique crystallography applications.
The “Lab in the Spotlight” section highlights a different laboratory from the global community of X-ray diffraction facilities. In this month’s edition, Macromolecular Crystallography Laboratory is featured, highlighting the investigation - mainly by high-resolution X-ray diffraction – of the relationship between protein structure and function, revealing structural features of macromolecules that could explain their importance to understanding cancer and AIDS.
Recently published scientific papers, book reviews, a schedule of upcoming events, and a link to the Rigaku Oxford Diffraction user forum are also included.
Crystallography Times is published monthly. Readers can subscribe to the newsletter or view the current issue online at https://www.rigaku.com/subscribe.
About Rigaku Oxford Diffraction (ROD)
ROD was formed as the global single crystal business unit of Rigaku Corporation after the acquisition of the former Oxford Diffraction organization from Agilent Technologies in 2015. ROD is a leader in the field of single crystal analysis, both in the field of chemical crystallography as well as well as macromolecular crystallography. Formed in 1951, Rigaku Corporation is a leading analytical instrumentation company based out of Tokyo, Japan.
For further information, contact:
Michael Nelson
Rigaku Global Marketing Group
tel: +1. 512-225-1796
michael.nelson(at)rigaku(dot)com
